FDA Inspection 1210861 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on Jul 14, 2023 in Cleveland, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Cleveland, MS (United States)